Published in Pain Res Treat on December 10, 2012
The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med (2014) 1.13
The Translational Significance of the Neurovascular Unit: A Mini-Review. J Biol Chem (2016) 0.75
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev (2005) 7.56
Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell (2005) 7.41
Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med (1987) 6.45
The gap junction communication channel. Cell (1996) 5.95
Glial regulation of the cerebral microvasculature. Nat Neurosci (2007) 5.91
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature (2004) 5.87
Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev (2006) 5.46
Structural basis of integrin activation by talin. Cell (2007) 5.37
Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci (1999) 5.02
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell (2006) 4.53
The tail of integrins, talin, and kindlins. Science (2009) 4.51
Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell (2003) 4.19
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med (2008) 3.83
Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct (2001) 3.74
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (2000) 3.71
Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab (2011) 3.57
Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol (2005) 3.54
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science (2011) 3.52
Integrin structure. Biochem Soc Trans (2000) 3.49
Signaling at the gliovascular interface. J Neurosci (2003) 3.16
Regulation of synaptic connectivity by glia. Nature (2010) 3.02
Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol (2007) 2.94
Interactions between the immune and nervous systems in pain. Nat Med (2010) 2.91
Central nervous system pericytes in health and disease. Nat Neurosci (2011) 2.90
The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem (2009) 2.90
Integrin-mediated short-term memory in Drosophila. Nature (1998) 2.68
Pannexin 1: the molecular substrate of astrocyte "hemichannels". J Neurosci (2009) 2.48
Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science (2008) 2.46
Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37
Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J Cell Biol (2002) 2.35
Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci U S A (2001) 2.35
Regulation of integrin activation. Annu Rev Cell Dev Biol (2011) 2.32
Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J Biol Chem (2009) 2.27
Linking integrin conformation to function. J Cell Sci (2009) 2.15
Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem (2006) 2.14
Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development (2004) 2.14
Integrins in immunity. J Cell Sci (2009) 2.02
Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci (2005) 1.85
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A (2000) 1.75
The biochemistry and function of pannexin channels. Biochim Biophys Acta (2012) 1.70
Integrin requirement for hippocampal synaptic plasticity and spatial memory. J Neurosci (2003) 1.66
PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes. Neuron (2004) 1.61
Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J Neurosci (2003) 1.59
Pathogenetic mechanisms of hepatic encephalopathy. Gut (2008) 1.59
Astroglial networks scale synaptic activity and plasticity. Proc Natl Acad Sci U S A (2011) 1.56
Pannexins in ischemia-induced neurodegeneration. Proc Natl Acad Sci U S A (2011) 1.55
Biological role of connexin intercellular channels and hemichannels. Arch Biochem Biophys (2012) 1.45
Beta 1-integrins are required for hippocampal AMPA receptor-dependent synaptic transmission, synaptic plasticity, and working memory. J Neurosci (2006) 1.42
Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci (2009) 1.39
The cell biology of synaptic plasticity. Science (2011) 1.37
Structural and functional studies with antibodies to the integrin beta 2 subunit. A model for the I-like domain. J Biol Chem (2000) 1.34
Distinct roles of the beta 1-class integrins at the developing and the mature hippocampal excitatory synapse. J Neurosci (2006) 1.32
Deletion of astroglial connexins weakens the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.30
Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol (2005) 1.28
Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol (2009) 1.25
The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J Clin Invest (2011) 1.21
The mechanisms of microgliosis and pain following peripheral nerve injury. Exp Neurol (2011) 1.19
Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics (2010) 1.19
Structure and allosteric regulation of the alpha X beta 2 integrin I domain. Proc Natl Acad Sci U S A (2003) 1.18
Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain (2011) 1.15
Arg-Gly-Asp-Ser-selective adhesion and the stabilization of long-term potentiation: pharmacological studies and the characterization of a candidate matrix receptor. J Neurosci (1997) 1.14
The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J Neuroimmune Pharmacol (2012) 1.13
Alpha3 integrin receptors contribute to the consolidation of long-term potentiation. Neuroscience (2002) 1.12
Schwann cell migration is integrin-dependent and inhibited by astrocyte-produced aggrecan. Glia (2010) 1.06
Role of astrocytes in brain function and disease. Toxicol Pathol (2010) 1.06
Leukocyte adhesion deficiency: molecular basis and functional consequences. Immunodefic Rev (1988) 1.06
Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin (2010) 1.06
Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia (2006) 1.04
An inhibitor of integrin receptors blocks long-term potentiation. Behav Neural Biol (1990) 1.02
Histochemical studies in experimental portal-systemic encephalopathy. Arch Neurol (1976) 1.00
Chronic inflammatory pain and the neurovascular unit: a central role for glia in maintaining BBB integrity? Curr Pharm Des (2008) 1.00
Integrin-mediated regulation of neurovascular development, physiology and disease. Cell Adh Migr (2009) 1.00
Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol (2010) 1.00
Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur J Neurosci (2003) 0.98
Developmental control of synaptic receptivity. J Neurosci (2008) 0.97
Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience (2005) 0.97
Direct Thy-1/alphaVbeta3 integrin interaction mediates neuron to astrocyte communication. Biochim Biophys Acta (2008) 0.97
Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol (2010) 0.94
Alpha3-integrins are required for hippocampal long-term potentiation and working memory. Learn Mem (2007) 0.93
Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine. Neurochem Int (2003) 0.93
Neuron-astrocyte communication and synaptic plasticity. Curr Opin Neurobiol (2010) 0.92
Integrins in the development, function and dysfunction of the nervous system. Front Biosci (2003) 0.92
Vascular matrix adhesion and the blood-brain barrier. Biochem Soc Trans (2006) 0.90
α8-integrins are required for hippocampal long-term potentiation but not for hippocampal-dependent learning. Genes Brain Behav (2010) 0.88
Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition. EMBO Mol Med (2011) 0.88
Sonic hedgehog regulates integrin activity, cadherin contacts, and cell polarity to orchestrate neural tube morphogenesis. J Neurosci (2009) 0.87
Sonic hedgehog: a key mediator of anterior-posterior patterning of the limb and dorso-ventral patterning of axial embryonic structures. Biochem Soc Trans (1994) 0.87
Conditional deletion of the Itgb4 integrin gene in Schwann cells leads to delayed peripheral nerve regeneration. J Neurosci (2008) 0.87
Astrocytic αVβ3 integrin inhibits neurite outgrowth and promotes retraction of neuronal processes by clustering Thy-1. PLoS One (2012) 0.84
Down-regulation of glutamine synthetase enhances migration of rat astrocytes after in vitro injury. Neurochem Int (2010) 0.81
Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. Clin Biochem (2005) 0.81
Ischemia alters the expression of connexins in the aged human brain. J Biomed Biotechnol (2009) 0.79
Neural tube morphogenesis. Curr Opin Genet Dev (1997) 0.78
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science (2008) 3.51
Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity (2006) 3.11
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci U S A (2007) 2.27
Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity (2004) 1.98
Importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry (2006) 1.87
Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med (2008) 1.76
Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1. J Biol Chem (2002) 1.61
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther (2009) 1.55
Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling. Blood (2007) 1.52
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci U S A (2004) 1.49
New fluorescence correlation spectroscopy enabling direct observation of spatiotemporal dependence of diffusion constants as an evidence of anomalous transport in extracellular matrices. Biophys J (2005) 1.37
Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci U S A (2004) 1.35
Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J Immunol (2009) 1.33
Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci U S A (2006) 1.32
An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin alphaLbeta2. Proc Natl Acad Sci U S A (2005) 1.30
Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion. J Biol Chem (2005) 1.24
Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc Natl Acad Sci U S A (2005) 1.24
Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut. J Clin Invest (2007) 1.23
Structure and allosteric regulation of the alpha X beta 2 integrin I domain. Proc Natl Acad Sci U S A (2003) 1.18
The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1. J Immunol (2004) 1.18
Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes. Blood (2009) 1.15
Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1. J Biol Chem (2002) 1.14
Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity. Nat Biotechnol (2003) 1.13
Transition from rolling to firm adhesion can be mimicked by extension of integrin alphaLbeta2 in an intermediate affinity state. J Biol Chem (2006) 1.12
Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J (2009) 1.12
The integrin alpha-subunit leg extends at a Ca2+-dependent epitope in the thigh/genu interface upon activation. Proc Natl Acad Sci U S A (2004) 1.11
Azi-isoflurane, a Photolabel Analog of the Commonly Used Inhaled General Anesthetic Isoflurane. ACS Chem Neurosci (2009) 1.08
A small molecule agonist of an integrin, alphaLbeta2. J Biol Chem (2006) 1.04
The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J (2008) 1.02
Set positive end-expiratory pressure during protective ventilation affects lung injury. Anesthesiology (2002) 0.99
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J Leukoc Biol (2006) 0.98
Essential roles of VLA-4 in the hematopoietic system. Int J Hematol (2010) 0.96
Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin. J Biol Chem (2007) 0.95
Open-lung protective ventilation with pressure control ventilation, high-frequency oscillation, and intratracheal pulmonary ventilation results in similar gas exchange, hemodynamics, and lung mechanics. Anesthesiology (2003) 0.95
The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials (2004) 0.94
Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J (2012) 0.94
Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology (2010) 0.93
Genetic perturbation of the putative cytoplasmic membrane-proximal salt bridge aberrantly activates alpha(4) integrins. Blood (2008) 0.91
The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials (2004) 0.91
Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1. Proc Natl Acad Sci U S A (2009) 0.90
Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting. Nat Biotechnol (2003) 0.89
Isoflurane inhibits neutrophil recruitment in the cutaneous Arthus reaction model. J Anesth (2012) 0.89
Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy. Clin Cancer Res (2004) 0.87
Absorption spectrum of surface-bound cap-shaped gold particles. Opt Lett (2002) 0.86
Sedative drug modulates T-cell and lymphocyte function-associated antigen-1 function. Anesth Analg (2011) 0.86
[A case of previously undiagnosed methemoglobinemia exhibiting sustained low SpO2 value at the induction of general anesthesia]. Masui (2013) 0.85
Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis. Crit Care Res Pract (2012) 0.85
Antibody-mediated delivery of siRNAs for anti-HIV therapy. Methods Mol Biol (2011) 0.85
Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain. Biol Pharm Bull (2007) 0.85
Anti-integrin therapy for multiple sclerosis. Autoimmune Dis (2012) 0.84
Anti-angiogenic effects of dimethyl sulfoxide on endothelial cells. Biol Pharm Bull (2003) 0.84
Accumulation of visceral fat in maintenance hemodialysis patients. Clin Exp Nephrol (2011) 0.83
Volatile anesthetics, not intravenous anesthetic propofol bind to and attenuate the activation of platelet receptor integrin αIIbβ3. PLoS One (2013) 0.82
Optimal site-specific PEGylation of mutant TNF-alpha improves its antitumor potency. Biochem Biophys Res Commun (2004) 0.82
Enhancement of electroluminescence through a two-dimensional corrugated metal film by grating-induced surface-plasmon cross coupling. Opt Lett (2005) 0.82
Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window. Clin Cancer Res (2004) 0.82
An infantile-juvenile form of Alexander disease caused by a R79H mutation in GFAP. Brain Dev (2005) 0.80
Propofol shares the binding site with isoflurane and sevoflurane on leukocyte function-associated antigen-1. Anesth Analg (2013) 0.80
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone. Breast Cancer (2012) 0.80
Activated protein C stimulates osteoblast proliferation via endothelial protein C receptor. Thromb Res (2009) 0.79
Systemic siRNA delivery to leukocyte-implicated diseases. Cell Cycle (2009) 0.79
Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody. Inflamm Bowel Dis (2010) 0.79
The connection between metal ion affinity and ligand affinity in integrin I domains. Biochim Biophys Acta (2007) 0.79
Poly(vinylpyrrolidone-co-dimethyl maleic acid) as a novel renal targeting carrier. J Control Release (2004) 0.79
Direct observation of spatiotemporal dependence of anomalous diffusion in inhomogeneous fluid by sampling-volume-controlled fluorescence correlation spectroscopy. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.78
An in vitro method for screening anti-platelet agents using a microchannel array flow analyzer. Biorheology (2010) 0.76
Enhanced infrared LSPR sensitivity of cap-shaped gold nanoparticles coupled to a metallic film. Langmuir (2014) 0.76
Incorporation of adult organ-derived endothelial cells into tumor blood vessel. Biochem Biophys Res Commun (2003) 0.75
A novel cytomedical vehicle capable of protecting cells against complement. Biochem Biophys Res Commun (2003) 0.75
Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo. Methods Mol Biol (2012) 0.75
Conformational regulation of integrin activation in drug discovery. Rinsho Ketsueki (2014) 0.75
Effective accumulation of poly(vinylpyrrolidone-co-vinyl laurate) into the spleen. J Biomed Mater Res A (2004) 0.75
Development of a novel cytomedical treatment that can protect entrapped cells from host humoral immunity. Cell Transplant (2002) 0.75
Morphology Effects of Cap-shaped Silver Nanoparticle Films as a SERS Platform. Anal Sci (2016) 0.75
Surface exciton polaritons supported by a J-aggregate-dye/air interface at room temperature. Opt Lett (2017) 0.75
Selective enhancer of tumor vascular permeability for optimization of cancer chemotherapy. Biol Pharm Bull (2004) 0.75
Generation of broadband longitudinal fields for applications to ultrafast tip-enhanced near-field microscopy. Opt Express (2011) 0.75
Lentiviral gene transfer method to study integrin function in T lymphocytes. Methods Mol Biol (2012) 0.75
Amla (Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells. Br J Nutr (2013) 0.75
Up-Regulation of CD74 Expression in Parietal Epithelial Cells in a Mouse Model of Focal Segmental Glomerulosclerosis. Nephron (2016) 0.75
Fabricating two-dimensional plasmonic photonic crystals for the modulation of nanocavity plasmon mode. Nanoscale (2016) 0.75
[Control of activation of a cell adhesion molecule, integrin]. Masui (2006) 0.75
Combination effects of complement regulatory proteins and anti-complement polymer. Biochim Biophys Acta (2003) 0.75
A novel method for construction of gene fragment library to searching epitopes. Biochem Biophys Res Commun (2006) 0.75
A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis. Clin Exp Nephrol (2011) 0.75
New method for detecting antiandrogenic effects through the measurement of external genitalia in rabbits. Congenit Anom (Kyoto) (2010) 0.75